Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 72,098 shares, an increase of ∞ from the July 15th total of 0 shares. Based on an average daily volume of 417 shares, the short-interest ratio is presently 172.9 days.
Viva Biotech Stock Performance
Shares of VBIZF opened at $0.17 on Monday. Viva Biotech has a 1 year low of $0.13 and a 1 year high of $0.20. The stock’s 50-day moving average price is $0.16 and its two-hundred day moving average price is $0.26.
About Viva Biotech
Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.
With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.
See Also
- Five stocks we like better than Viva Biotech
- 3 Robotics Stocks Under $10: Value, Momentum, or Bet?
- 3 ETFs Built to Protect Your Money if the Bull Market Breaks
- JFrog’s AI Opportunity Could Fuel a Big Leap in Share Price
- Is SiTime the Best AI Stock You’ve Never Heard Of?
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
